Teva Pharmaceutical Industries (TEVA) Divestments: 2020-2025
Historic Divestments for Teva Pharmaceutical Industries (TEVA) over the last 6 years, with Sep 2025 value amounting to $8.0 million.
- Teva Pharmaceutical Industries' Divestments fell 78.95% to $8.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $38.0 million, marking a year-over-year decrease of 63.81%. This contributed to the annual value of $43.0 million for FY2024, which is 36.76% down from last year.
- According to the latest figures from Q3 2025, Teva Pharmaceutical Industries' Divestments is $8.0 million, which was down 11.11% from $9.0 million recorded in Q2 2025.
- In the past 5 years, Teva Pharmaceutical Industries' Divestments registered a high of $138.0 million during Q1 2021, and its lowest value of $1.0 million during Q2 2024.
- Over the past 3 years, Teva Pharmaceutical Industries' median Divestments value was $9.0 million (recorded in 2025), while the average stood at $16.1 million.
- Per our database at Business Quant, Teva Pharmaceutical Industries' Divestments surged by 2,200.00% in 2021 and then crashed by 98.21% in 2024.
- Teva Pharmaceutical Industries' Divestments (Quarterly) stood at $42.0 million in 2021, then tumbled by 45.24% to $23.0 million in 2022, then surged by 400.00% to $10.0 million in 2023, then soared by 280.00% to $4.0 million in 2024, then slumped by 78.95% to $8.0 million in 2025.
- Its Divestments was $8.0 million in Q3 2025, compared to $9.0 million in Q2 2025 and $17.0 million in Q1 2025.